MX2018014932A - Preparacion externa para la piel para mejora de arrugas. - Google Patents
Preparacion externa para la piel para mejora de arrugas.Info
- Publication number
- MX2018014932A MX2018014932A MX2018014932A MX2018014932A MX2018014932A MX 2018014932 A MX2018014932 A MX 2018014932A MX 2018014932 A MX2018014932 A MX 2018014932A MX 2018014932 A MX2018014932 A MX 2018014932A MX 2018014932 A MX2018014932 A MX 2018014932A
- Authority
- MX
- Mexico
- Prior art keywords
- skin
- branched
- linear
- alkyl group
- compound
- Prior art date
Links
- 230000037303 wrinkles Effects 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000014759 maintenance of location Effects 0.000 abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 230000002500 effect on skin Effects 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 230000035515 penetration Effects 0.000 abstract 1
- -1 polysiloxane Polymers 0.000 abstract 1
- 229920001296 polysiloxane Polymers 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000009759 skin aging Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/025—Explicitly spheroidal or spherical shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se proporciona un método para mejorar la retención dérmica de un compuesto, el compuesto que es efectivo para la prevención o mejora del envejecimiento de la piel. La preparación externa en forma de gel de aceite para la piel que contiene: 1) un compuesto representado por la siguiente Fórmula General (1), un isómero del mismo y/o una sal farmacéuticamente aceptable del mismo; y 2) un metil polisiloxano parcialmente reticulado; de la presente invención permite la fácil penetración del componente efectivo de 1) de la preparación en la piel mientras que aumenta la capacidad de absorción percutánea y mejora la retención intradérmica. (ver Fórmula) [En la fórmula, R1 representa un grupo alquilo lineal o ramificado de C1-C4 sustituido por un grupo(s) carboxilo, o un grupo alquilo lineal o ramificado de C1-C4 sustituido por un grupo(s) de éster de ácido carboxílico que tiene una cadena alquilo de C1-C4, y R2 y R3 cada uno independientemente representa un grupo alquilo lineal o ramificado de C1-C4].
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016125685 | 2016-06-24 | ||
| PCT/JP2017/022824 WO2017221973A1 (ja) | 2016-06-24 | 2017-06-21 | シワ改善用の皮膚外用剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018014932A true MX2018014932A (es) | 2019-04-24 |
| MX384082B MX384082B (es) | 2025-03-14 |
Family
ID=60783440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018014932A MX384082B (es) | 2016-06-24 | 2017-06-21 | Preparación externa para la piel para mejora de arrugas. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US11413224B2 (es) |
| EP (2) | EP3476381B1 (es) |
| JP (2) | JP6554752B2 (es) |
| KR (1) | KR102431188B1 (es) |
| CN (2) | CN113693965B (es) |
| AU (1) | AU2017282393B2 (es) |
| BR (1) | BR112018073968B1 (es) |
| CA (1) | CA3026270C (es) |
| ES (1) | ES2905761T3 (es) |
| IL (2) | IL263275B (es) |
| MX (1) | MX384082B (es) |
| MY (2) | MY189548A (es) |
| RU (1) | RU2743039C2 (es) |
| SG (1) | SG11201810731WA (es) |
| TW (2) | TWI720214B (es) |
| UA (1) | UA122923C2 (es) |
| WO (1) | WO2017221973A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3080894A1 (en) * | 2017-11-15 | 2019-05-23 | Pola Chemical Industries, Inc. | Oil-based composition |
| JP2019206485A (ja) * | 2018-05-29 | 2019-12-05 | ポーラ化成工業株式会社 | シワ改善用組成物 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3242874A (en) | 1963-10-25 | 1966-03-29 | Fisher & Ludlow Ltd | Conveyors for conveying goods |
| JPS492483B1 (es) | 1969-01-28 | 1974-01-21 | ||
| US5296591A (en) | 1990-12-31 | 1994-03-22 | Fujisawa Pharmaceutical Co., Ltd. | Trifluoromethylketone derivatives, processes for preparation thereof and use thereof |
| JP3492483B2 (ja) | 1996-10-03 | 2004-02-03 | 株式会社資生堂 | ゲル状皮膚外用剤 |
| KR100207078B1 (ko) | 1996-10-18 | 1999-07-15 | 윤종용 | 세탁기 |
| JP2002161051A (ja) | 1996-12-24 | 2002-06-04 | Fujisawa Pharmaceut Co Ltd | 脳虚血性疾患等の治療剤 |
| FR2757380B1 (fr) | 1996-12-24 | 1999-01-29 | Oreal | Composition de maquillage ou de soin, sans transfert, contenant un organopolysiloxane et une phase grasse |
| KR19990043352A (ko) | 1997-11-29 | 1999-06-15 | 전주범 | 학습능률을 위한 모니터의 화면밝기 조정장치 및 그 방법 |
| JP4320791B2 (ja) | 1998-02-24 | 2009-08-26 | アステラス製薬株式会社 | 皮ふの老化の予防、治療剤 |
| JP2001040263A (ja) | 1999-07-29 | 2001-02-13 | Pentel Corp | 水性光沢インキ組成物 |
| CN1407902A (zh) * | 1999-10-12 | 2003-04-02 | 藤泽药品工业株式会社 | 难治性创伤的治疗剂 |
| WO2001040263A1 (fr) | 1999-12-03 | 2001-06-07 | Ono Pharmaceutical Co., Ltd. | Derives de 1,3,4-oxadiazoline-2-one et medicaments contenant ces derives utiles comme ingredient actif |
| EP1136064A3 (en) * | 2000-03-21 | 2001-10-17 | Avon Products, Inc. | Method for improving the apperance of skin and topical compositions for practicing the same |
| JP2002255847A (ja) | 2001-02-26 | 2002-09-11 | Miyagi Kagaku Kogyo Kk | コラーゲン産生促進剤、それを含む機能性食品および医薬品 |
| JP2003300851A (ja) | 2002-04-10 | 2003-10-21 | Pola Chem Ind Inc | フレグランス組成物 |
| JP4336486B2 (ja) | 2002-10-04 | 2009-09-30 | 一丸ファルコス株式会社 | ヒアルロン酸産生促進剤 |
| FR2856924B1 (fr) * | 2003-07-02 | 2008-08-22 | Oreal | Composition cosmetique contenant un elastomere de silicone et un polymere silicone bloc |
| JP2005041795A (ja) * | 2003-07-24 | 2005-02-17 | P & P F:Kk | 凹凸補正用油性化粧料 |
| US20090011035A1 (en) * | 2007-07-03 | 2009-01-08 | Joseph Michael Zukowski | Personal care composition |
| MY159355A (en) * | 2008-11-19 | 2016-12-30 | Pola Chem Ind Inc | Anti-wrinkle agents |
| WO2012124436A1 (ja) * | 2011-03-17 | 2012-09-20 | 株式会社 資生堂 | 皮膚化粧料 |
| JP6536321B2 (ja) * | 2014-10-01 | 2019-07-03 | 日油株式会社 | オイルゲル化粧料 |
-
2017
- 2017-06-21 RU RU2018142778A patent/RU2743039C2/ru active
- 2017-06-21 TW TW106120746A patent/TWI720214B/zh active
- 2017-06-21 CA CA3026270A patent/CA3026270C/en active Active
- 2017-06-21 EP EP17815441.5A patent/EP3476381B1/en active Active
- 2017-06-21 EP EP21208135.0A patent/EP4008304B1/en active Active
- 2017-06-21 ES ES17815441T patent/ES2905761T3/es active Active
- 2017-06-21 CN CN202111020188.2A patent/CN113693965B/zh active Active
- 2017-06-21 MY MYPI2018002290A patent/MY189548A/en unknown
- 2017-06-21 BR BR112018073968-5A patent/BR112018073968B1/pt active IP Right Grant
- 2017-06-21 UA UAA201812003A patent/UA122923C2/uk unknown
- 2017-06-21 MX MX2018014932A patent/MX384082B/es unknown
- 2017-06-21 US US16/306,881 patent/US11413224B2/en active Active
- 2017-06-21 TW TW109140918A patent/TWI734647B/zh active
- 2017-06-21 CN CN201780035325.5A patent/CN109310585B/zh active Active
- 2017-06-21 JP JP2017535474A patent/JP6554752B2/ja active Active
- 2017-06-21 MY MYPI2021005518A patent/MY194060A/en unknown
- 2017-06-21 SG SG11201810731WA patent/SG11201810731WA/en unknown
- 2017-06-21 KR KR1020187034232A patent/KR102431188B1/ko active Active
- 2017-06-21 AU AU2017282393A patent/AU2017282393B2/en active Active
- 2017-06-21 WO PCT/JP2017/022824 patent/WO2017221973A1/ja unknown
-
2018
- 2018-11-25 IL IL263275A patent/IL263275B/en active IP Right Grant
- 2018-12-26 JP JP2018242879A patent/JP7016794B2/ja active Active
-
2020
- 2020-04-22 IL IL274153A patent/IL274153B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2021000400A1 (es) | Métodos para reducir la necesidad de revascularización arterial periférica en un sujeto tratado con estatinas. | |
| NI201400155A (es) | Métodos para reducir el riesgo de un evento cardiovascular en un sujeto con terapia con estatina | |
| AR106141A1 (es) | Métodos e intermediarios para la preparación de derivados de ácidos biliares | |
| CR20150491A (es) | 3-pirimidin-4-il oxazolidin -2- onas como inhibidores de idh mutante | |
| AR090456A1 (es) | Combinaciones farmaceuticas que comprenden un analogo de tionucleotidos | |
| UY35126A (es) | Ojo es alfa | |
| DOP2014000023A (es) | Cosmético que contiene enzima exfoliante. | |
| HK1204447A1 (en) | Compositions and methods of use of phorbol esters | |
| MX2015012886A (es) | Compuestos aromaticos sustituidos para el tratamiento de la fibrosis pulmonar, la fibrosis hepatica, la fibrosis de la piel y la fibrosis cardiaca. | |
| CL2015003602A1 (es) | Composiciones y métodos para tratar anemia. | |
| CR20150663A (es) | Derivados de diazacarbazol como ligandos de tau para pet | |
| BR112014028042A2 (pt) | inibidores de nampt | |
| MX2016013299A (es) | Composiciones de vacuna. | |
| CL2017000120A1 (es) | Composiciones en suspensión de ciclosporina a para inyecciones subconjuntivales y perioculares | |
| EA201592268A1 (ru) | Дигидропиридиноновые ингибиторы mgat2 | |
| MX2020004930A (es) | Compuestos de biarilo sustituido novedosos como inhibidores de indolamina 2,3-dioxigenasa (ido). | |
| AR084597A1 (es) | Uso de estabilizadores de glutamina | |
| AR095015A1 (es) | Compuestos de azetidiniloxifenilpirrolidina | |
| EA201591259A1 (ru) | Твёрдые формы производного хиназолина и их применение в качестве ингибитора braf | |
| MX2018014932A (es) | Preparacion externa para la piel para mejora de arrugas. | |
| EA201591434A1 (ru) | Способ обеспечения глазной нейропротекции | |
| BR112017023144A2 (pt) | composições cosméticas compreendendo ésteres de estolídeo e usos para o tratamento capilar | |
| AR104539A1 (es) | Compuestos cíclicos | |
| BR112015009988A2 (pt) | melhoramentos em compostos orgânicos ou relativos | |
| MX388141B (es) | EL USO DE DERIVADOS DE ÁCIDOS GRASOS POLINSATURADOS PARA REDUCIR apoC-III. |